1,7-phenanthroline has been researched along with Granulocytic Leukemia, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviles-Vazquez, S; Ayala-Sanchez, M; Bravo-Gomez, ME; Centeno-Llanos, S; Chavez-Gonzalez, A; Mayani, H; Moreno-Lorenzana, D; Ruiz-Azuara, L; Sandoval-Esquivel, MA; Torres-Martinez, H | 1 |
| Amiel, A; Einat, M; Fabian, I; Kashman, Y; Lishner, M; Markel, D; Nagler, A; Rudi, A; Yarkorli, S | 1 |
| Amiel, A; Einat, M; Fabian, I; Fejgin, MD; Kashman, Y; Nagler, A; Rudi, A | 1 |
| Brown, WE; Czupryn, M; Vallee, BL | 1 |
| Bérczi, A; Crane, FL; Faulk, WP; Sizensky, JA | 1 |
| Advani, SH; Chitnis, MP; Kamath, NS; Satyamoorthy, K | 1 |
6 other study(ies) available for 1,7-phenanthroline and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia.
Topics: Antineoplastic Agents; Cell Cycle; Cell Death; Cell Proliferation; Coordination Complexes; Copper; Hematopoietic Stem Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Phenanthrolines; Reactive Oxygen Species; Tumor Cells, Cultured | 2017 |
Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Agents; Bone Marrow; Cell Division; Cell Survival; Child; Child, Preschool; Cytarabine; Female; Hematopoietic Stem Cells; Humans; In Situ Hybridization, Fluorescence; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Phenanthrolines; Tumor Cells, Cultured | 1995 |
Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin.
Topics: Animals; Antineoplastic Agents; CHO Cells; Cricetinae; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-11; Interleukin-3; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenanthrolines; Stem Cell Factor; Tumor Stem Cell Assay | 1996 |
Zinc rapidly induces a metal response element-binding factor.
Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Nucleus; DNA Probes; DNA-Binding Proteins; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lung Neoplasms; Molecular Sequence Data; Molecular Weight; Nuclear Proteins; Oligonucleotide Probes; Phenanthrolines; Sulfates; Tumor Cells, Cultured; Zinc; Zinc Sulfate | 1992 |
Diferric transferrin reduction by K562 cells. A critical study.
Topics: Ferricyanides; Ferrozine; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytes; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Phenanthrolines; Reproducibility of Results; Spectrophotometry; Transferrin; Tumor Cells, Cultured | 1991 |
1,10-phenanthroline potentiates cytotoxicity of hydroxyurea in human chronic myeloid leukemia cells.
Topics: DNA; Drug Synergism; Humans; Hydroxyurea; Iron; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes; Phenanthrolines; Zinc | 1989 |